Marc Lustig

PharmaCielo Cannabis Co. Sees 390% YoY Revenue Jump As Losses Narrow In Q2 2024

PharmaCielo Cannabis Co. Narrows Net Loss By 31% YoY In Q1, CEO Says Cost Reduction Efforts Showing Results

This Latin American Cannabis Co. Plans To Expand In Thailand Amid Significant Shifts In Weed Regulation Landscape

PharmaCielo Cannabis Co. Narrows Net Loss By 31% YoY In Q1, CEO Says Cost Reduction Efforts Showing Results

This Latin American Cannabis Co. Plans To Expand In Thailand Amid Significant Shifts In Weed Regulation Landscape

Cannabis Companies Partner To Provide Seed-to-Pharma Products Globally

Top Cannabis Industry Leaders Who Took The Reins In 2023

Cannabis Companies Partner To Provide Seed-to-Pharma Products Globally

Top Cannabis Industry Leaders Who Took The Reins In 2023

Cannabis Extracts Producer PharmaCielo Narrows Loss, Cuts Expenses In Q3, CEO Projects Higher Profitability

PharmaCielo Q2 2023 Results: Revenue Drops But CEO Is Optimistic About Future Growth

Marc Lustig Recent News

Marc Lustig Increases Ownership In IM Cannabis Via L5 Capital Debt Settlement

IM Cannabis Corp. (NASDAQ: IMCC) (CSE:IMCC), has closed the securities for debt settlement transaction with L5 Capital Inc., a company wholly-owned and controlled by Marc Lustig, the executive chairman and a director of the company.

IM Cannabis To Raise Up To $5.5M Via Private Placement Offerings

IM Cannabis Corp. (NASDAQ: IMCC) (CSE:IMCC) announced a non-brokered private placement of a minimum of 400,000 units and a maximum of 2.96 million units of the company at a price of $1.25 per unit for aggregate gros

IM Cannabis To Raise Up To $5M Via Private Placement Led By Management

IM Cannabis Corp. (NASDAQ: IMCC) (CSE:IMCC) is undertaking a non-brokered private placement for aggregate gross proceeds of up to $5 million.